Journal of Bioanalysis & Biomedicine

ISSN: 1948-593X

Open Access

Mathieu Verbeken


  • Research Article
    Purity profiling of Peptide Drugs
    Author(s): Sylvia Van Dorpe, Mathieu Verbeken, Evelien Wynendaele and Bart De SpiegeleerSylvia Van Dorpe, Mathieu Verbeken, Evelien Wynendaele and Bart De Spiegeleer

    The quality of a peptide drug mainly depends on its impurity profile, with the emphasis on the related impurities. These impurities may be biomedically active, alter the desired efficacy or induce unwanted toxicity, an aspect which is termed the “functional quality” of the peptide drug. Therefore, regulatory authorities have set up guidances or have legally established specification limits to assure a consistent purity of these peptide drugs. For the active pharmaceutical ingredients (APIs), the pharmacopoeial monographs are legally binding. Additional information can be found in regional and international guidelines. For the finished pharmaceutical drug products (FDPs) containing peptide active ingredients, only general guidelines are available. The construction of a complete related-impurity profile is very challenging due to the wide availability of different protecting.. Read More»
    DOI: 10.4172/1948-593X.S6-003

    Abstract PDF

Relevant Topics

Google Scholar citation report
Citations: 3099

Journal of Bioanalysis & Biomedicine received 3099 citations as per Google Scholar report

Journal of Bioanalysis & Biomedicine peer review process verified at publons

Indexed In

arrow_upward arrow_upward